Is Now the Right Time to Buy NovoCure?

NovoCure (NASDAQ: NVCR) was one of the better-performing stocks of early 2021, but the big gains came to an end in June. Since peaking this summer, shares have lost more than 58% of their value.

Is the recent plunge an opportunity to buy a great medical device stock on sale, or is it the beginning of a longer slide? Here's what you should know before attempting to catch this falling knife.

Image source: NovoCure.

Continue reading

Source Fool.com